Suppr超能文献

[心脏起搏治疗在颈动脉窦综合征管理中的作用]

[The role of cardiac pacing therapy in the management of carotid sinus syndrome].

出版信息

Srp Arh Celok Lek. 2015 Jan-Feb;143(1-2):23-7. doi: 10.2298/sarh1502023r.

Abstract

INTRODUCTION

Carotid sinus syndrome is characterized by a hypersensitive carotid sinus and syncope. Although we have clear guidelines for the diagnosis and treatment of carotid sinus syndrome, the efficacy of pacing therapy with this indication has not been the subject of many studies.

OBJECTIVE

This study aimed to assess the efficacy and safety of pacing therapy in the treatment of patients with carotid sinus syndrome and to determine the factors contributing to symp- toms recurrence after pacemaker implantation.

METHODS

This study was retrospective and included 32 patients in whom a pacemaker was implanted due to carotid sinus syn- drome at the Pacemaker Center, Clinical Center of Serbia, be- tween April 2005 and April 2012. Carotid sinus massage and head-up tilt test (HUTT) were performed to select patients with cardioinhibitory and mixed type carotid sinus syndrome, who were enrolled to the study.

RESULTS

The mean age of patients was 65.6 ± 11.5 years and 20 (62.5%) were men. The mean follow-up period was 4.3 ± 1.9 years. HUTT was performed in 3 (9.4%) patients. Twenty-seven (84.4%) patients presented with cardioinhibitory and 5 (15.6%) with mixed type of carotid sinus syndrome. After pacemaker implantation, 22 (68.7%) patients had no further symptoms, 8 (25.0%) had syncope and 2 (6.3%) presyncope.The mixed type of the disease (HR 3.1; 95% CI 1.4-5.1; p = 0.021) and implanta- tion of pacemaker in WI mode (HR 1.8; 95% CI 1.1-3.2; p = 0.034) were independent predictors of symptoms recurrence. There were 3 (9.4%) perioperative surgical complications.

CONCLUSION

Pacemaker therapy is an effective and safe treat- ment for patients with carotid sinus syndrome. As predictors of symptoms persistence after pacemaker implantation in our population, we identified the implantation of pacemaker in WI mode and the mixed type of carotid sinus syndrome.

摘要

引言

颈动脉窦综合征的特征是颈动脉窦过敏和晕厥。尽管我们有关于颈动脉窦综合征诊断和治疗的明确指南,但针对该适应症的起搏治疗效果尚未得到很多研究。

目的

本研究旨在评估起搏治疗对颈动脉窦综合征患者的疗效和安全性,并确定起搏器植入后导致症状复发的因素。

方法

本研究为回顾性研究,纳入了2005年4月至2012年4月期间在塞尔维亚临床中心起搏器中心因颈动脉窦综合征植入起搏器的32例患者。进行颈动脉窦按摩和头高位倾斜试验(HUTT)以选择心脏抑制型和混合型颈动脉窦综合征患者,这些患者被纳入研究。

结果

患者的平均年龄为65.6±11.5岁,男性20例(62.5%)。平均随访期为4.3±1.9年。3例(9.4%)患者进行了HUTT。27例(84.4%)患者表现为心脏抑制型,5例(15.6%)为混合型颈动脉窦综合征。起搏器植入后,22例(68.7%)患者无进一步症状,8例(25.0%)有晕厥,2例(6.3%)有晕厥前症状。疾病的混合型(HR 3.1;95%CI 1.4 - 5.1;p = 0.021)和以WI模式植入起搏器(HR 1.8;95%CI 1.1 - 3.2;p = 0.034)是症状复发的独立预测因素。有3例(9.4%)围手术期手术并发症。

结论

起搏器治疗对颈动脉窦综合征患者是一种有效且安全的治疗方法。作为我们人群中起搏器植入后症状持续的预测因素,我们确定了以WI模式植入起搏器和颈动脉窦综合征的混合型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验